The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

A new crop of companies is lining up to buy patient data from hospitals and sell it to those wanting to train AI or do ...

Fundings for Seattle-area startups lagged at the end of 2024, according to a new PitchBook-NVCA report, but they're off to a ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

US health systems and Regeneron Genetics Center launch the Truveta Genome Project, a $320M initiative to sequence up to 10M ...

At the J.P. Morgan Health Care conference, the future outlook for GLP-1 drugs used to treat obesity was a key focus, ...

The neuromuscular disease therapeutics market is projected to grow by $13.7B from 2025 to 2029, driven by advancements in AI, ...